Articles Referencing GHDX
Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIA
5/20/2013, 11:20 am from Minyanville in Investing, Stocks
Welcome to our daily roundup of top insider trades. Here's a
look at the most significant inside sales and purchases filed with
the SEC on Friday, May 17, 2013. Purchases: Felix Baker, a... Read >>
In Insider Trading, Harbinger Buys Spectrum Brands Stock for 11th Time Since April 9
5/17/2013, 11:17 am from Minyanville in Investing, Stocks
Welcome to our daily roundup of top insider trades. Here's a
look at the most significant inside sales and purchases filed with
the SEC on Thursday, May 16, 2013. Purchases: The investment... Read >>
Much Awaited Test Launch by Genomic - Analyst Blog
5/15/2013, 3:28 pm from Zacks.com in Investing, Business, Stocks
Recently, Genomic Health Inc. ( GHDX ) made available
its lead pipeline candidate Oncotype DX prostate cancer test to
physicians and their patients. This comes as a major boost to... Read >>
An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy Stock
5/15/2013, 10:23 am from Minyanville in Investing, Stocks
Welcome to our daily roundup of top insider trades. Here's a
look at the most significant inside sales and purchases filed with
the SEC on Tuesday, May 14, 2013. Purchases: Felix Baker, a... Read >>
Genomic Gains Coverage for DCIS - Analyst Blog
5/13/2013, 3:17 pm from Zacks.com in Investing, Business, Stocks
Genomic Health Inc. ( GHDX ) continues to
make strides towards establishing coverage for its Oncotype DX
breast cancer test. The company disclosed that the assigned
contractor for its... Read >>
GHDX Reports Loss, Beats on Revs - Analyst Blog
5/13/2013, 10:18 am from Zacks.com in Investing, Business, Stocks
Genomic Health ( GHDX ) reported
first-quarter 2013 net loss of $0.9 million, down from a net income
of $0.8 million in the year-ago period. The company's reported loss
of 3 cents per share... Read >>
GHDX to Show Prostate Test Result - Analyst Blog
4/5/2013, 4:06 pm from Zacks.com in Investing, Business, Stocks
Keeping in line with its strategy to launch its prostate cancer
test by the first half of 2013, Genomic Health,
Inc. ( GHDX ) set a
presentation at the American Urological Association... Read >>
Plethora of Positive Data for GHDX - Analyst Blog
3/18/2013, 5:45 pm from Zacks.com in Investing, Business, Stocks
Genomic Health Inc. ( GHDX ) continues to
demonstrate the clinical and economic merits of its Oncotype DX
breast cancer test. The company recently featured positive data
from 22 clinical... Read >>
Genomic Health Reveals Positive Results - Analyst Blog
3/14/2013, 5:47 pm from Zacks.com in Investing, Business, Stocks
Recently, Genomic Health ( GHDX ) announced the
positive result of a study on Oncotype DX to estimate the risk of
loco-regional recurrence (LRR) in node-positive, estrogen receptor
breast... Read >>
Genomic Reports 2 Study Results - Analyst Blog
3/5/2013, 5:40 pm from Zacks.com in Investing, Business, Stocks
Recently, Genomic Health ( GHDX ) announced the
results of 2 studies, which were conducted to determine
RNA-Sequencing and Mutation Identification, in the 14th Annual
Advances in Genome... Read >>
Genomic Beats Estimates - Analyst Blog
2/8/2013, 8:40 am from Zacks.com in Investing, Business, Stocks
Genomic Health ( GHDX ) reported
fourth-quarter 2012 net income of $2.0 million, down from $2.6
million in the year-ago period. The company's reported earnings per
share (EPS) of 6 cents... Read >>
Neutral on Genomic Health - Analyst Blog
1/8/2013, 2:50 pm from Zacks.com in Investing, Business, Stocks
We reaffirm our long-term 'Neutral' recommendation on
Genomic Health ( GHDX )
following the third quarter results. Despite an impressive growth
trajectory, the financial results of this... Read >>
Mid-Day Market Update: Monster Worldwide Continues to Rise While Markets Fall
11/8/2012, 1:14 pm from Benzinga in Investing, Commodities, Earnings, Economy, Investing Ideas
Midway through trading Thursday, the Dow traded down 0.42
percent to 12,877.82 while the NASDAQ fell 0.74 percent to
2,915.64. The S&P also fell, decreasing 0.57 percent to
1,386.52. ... Read >>
CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares
7/13/2012, 12:46 pm from GuruFocus in Investing
Genomic Health Inc. is a life science company focused on the
development and commercialization of genomic-based clinical
diagnostic tests for cancer that allow physicians and patients to
make... Read >>
Insiders are Spending MILLIONS on These 4 Small-Cap Stocks
4/10/2012, 11:30 am from Andy Obermueller in Investing, Investing Ideas
If you want someone to really pay attention to what you are
saying, then all you have to do is put your money where your mouth
is.
Consider the
CEO
of Company X. His stock price is in... Read >>